Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5773791 | 0.99 | ACHE (0.30) | STK17APTPN11 | |
| Hydrochloric Acid SCHEMBL5775437 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL5776452 | 0.97 | — | — | |
| SCHEMBL7959871 | 0.89 | KDM4E (0.35) | PTPN11MEN1KMT2ASMN1; SMN2TAAR1 | |
| Hydrochloric Acid SCHEMBL5773960 | 0.88 | KDM4E (0.34) | PTPN11MEN1KMT2ASMN1; SMN2TAAR1 | |
| SCHEMBL5776304 | 0.83 | PRCP (0.32) | — | |
| SCHEMBL5771094 | 0.83 | PARP1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL7182724 | 0.82 | PARP1 (0.30) | — | |
| Hydrochloric Acid SCHEMBL5775517 | 0.82 | MMP12 (0.32) | — | |
| Hydrochloric Acid SCHEMBL8125138 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | claimed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | claimed |